Carol S. Tang

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Interrupting glioblastoma malignant circuitry: plasticity traps, synaptic blockade, and myeloid reprogramming.

Interrupting glioblastoma malignant circuitry: plasticity traps, synaptic blockade, and myeloid reprogramming.

Journal: Current opinion in clinical nutrition and metabolic care
Published: January 08, 2026

Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma.

Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma.

Journal: Neuro-oncology
Published: June 15, 2025

ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy.

ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy.

Journal: Cancer research
Published: November 24, 2024

EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma.

EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma.

Journal: Neuro-oncology
Published: October 07, 2024

Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma.

Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma.

Journal: Neuro-oncology
Published: May 28, 2024

Magnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkers.

Magnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkers.

Journal: Nature communications
Published: April 16, 2024

Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide.

Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide.

Journal: Neuro-oncology
Published: February 17, 2024

Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma.

Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 17, 2023

Multiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors.

Multiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors.

Journal: Nature communications
Published: January 11, 2023

Integrative multi-omics approach to targeted therapy for glioblastoma.

Integrative multi-omics approach to targeted therapy for glioblastoma.

Journal: Pharmacological research
Published: March 30, 2022

Identification of Targets from LRRK2 Rescue Phenotypes.

Identification of Targets from LRRK2 Rescue Phenotypes.

Journal: Cells
Published: December 08, 2020

Kinomic profile in patient-derived glioma cells during hypoxia reveals c-MET-PI3K dependency for adaptation.

Kinomic profile in patient-derived glioma cells during hypoxia reveals c-MET-PI3K dependency for adaptation.

Journal: Theranostics
Published: October 20, 2020
Showing 1-12 of 31

Last Updated: 09/26/2026